Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
January 2017
in “
Journal of Antivirals & Antiretrovirals
”
Studysummary This retrospective study observed that breast cancer treatments disrupted normal blood counts and led to bone marrow suppression, highlighting the need for nutritional counseling to improve patient quality of life.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This retrospective study at the Bahawalpur Institute of Nuclear and Oncology in Pakistan involved 180 breast cancer patients and examined the impact of hormone receptor status on blood chemistry. The majority of patients were aged 41 to 60, with 57% at Stage III and 63.97% being post-menopausal. Half of the patients were ER/PR positive, and 23% had a triple positive status. Treatment varied based on hormone receptor status, with chemotherapy for hormone-negative patients, hormone therapy for hormone-responsive tumors, and monoclonal antibody therapy for Her-2 positive patients. The study found that treatment strategies affected hemogram values, leading to conditions like anemia, neutropenia, and nephrotoxicity. Adverse drug reactions included pain, fever, vomiting, hair loss, and lethargy. Nutritional counseling was recommended to improve patients' quality of life.
